In this instalment of our renewed clinical trials round-ups, we look at life sciences research and development announced during the week of 20th to 24th May, from early-stage onwards.
Faron Pharmaceuticals has been granted a Promising Innovative Medicines (PIM) designation in the UK for its lead product Traumakine, currently in phase 3 trials for Acute Respiratory Distre
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl